Listed

Reinsurance Group of America Inc: Form 10-Q for the period ended Jun 30, 2024

Filed with the SEC on Aug 2, 2024 and accepted by EDGAR at Aug 2, 2024, 14:24 ET.

Share

Management's discussion and analysis

As filed, 113,885 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Cautionary Note Regarding Forward-Looking Statements

This document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and federal securities laws including, among others, statements relating to projections of the future operations, strategies, earnings, revenues, income or loss, ratios, financial performance, and growth potential of the Company. Forward-looking statements often contain words and phrases such as “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “if,” “intend,” “likely,” “may,” “plan,” “potential,” “pro forma,” “project,” “should,” “will,” “would,” and other words and terms of similar meaning or that are otherwise tied to future periods or future performance, in each case in all derivative forms. Forward-looking statements are based on management’s current expectations and beliefs concerning future developments and their potential effects on the Company. Forward-looking statements are not a guarantee of future performance and are subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results, performance, and achievements could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.

Factors that could also cause results or events to differ, possibly materially, from those expressed or implied by forward-looking statements, include, among others: (1) adverse changes in mortality, morbidity, lapsation, or claims experience, (2) inadequate risk analysis and underwriting, (3) adverse capital and credit market conditions and their impact on the Company’s liquidity, access to capital, and cost of capital, (4) changes in the Company’s financial strength and credit ratings and the effect of such changes on the Company’s future results of operations and financial condition, (5) the availability and cost of collateral necessary for regulatory reserves and capital, (6) requirements to post collateral or make payments due to declines in the market value of assets subject to the Company’s collateral arrangements, (7) action by regulators who have authority over the Company’s reinsurance operations in the jurisdictions in which it operates, (8) the effect of the Company parent’s status as an insurance holding company and regulatory restrictions on its ability to pay principal of and interest on its debt obligations, (9) general economic conditions or a prolonged economic downturn affecting the demand for insurance and reinsurance in the Company’s current and planned markets, (10) the impairment of other financial institutions and its effect on the Company’s business, (11) fluctuations in U.S. or foreign currency exchange rates, interest rates, or securities and real estate markets, (12) market or economic conditions that adversely affect the value of the Company’s investment securities or result in the impairment of all or a portion of the value of certain of the Company’s investment securities that in turn could affect regulatory capital, (13) market or economic conditions that adversely affect the Company’s ability to make timely sales of investment securities, (14) risks inherent in the Company’s risk management and investment strategy, including changes in investment portfolio yields due to interest rate or credit quality changes, (15) the fact that the determination of allowances and impairments taken on the Company’s investments is highly subjective, (16) the stability of and actions by governments and economies in the markets in which the Company operates, including ongoing uncertainties regarding the amount of U.S. sovereign debt and the credit ratings thereof, (17) the Company’s dependence on third parties, including those insurance companies and reinsurers to which the Company cedes some reinsurance, third-party investment managers, and others, (18) financial performance of the Company’s clients, (19) the threat of natural disasters, catastrophes, terrorist attacks, pandemics, epidemics, or other major public health issues anywhere in the world where the Company or its clients do business, (20) competitive factors and competitors’ responses to the Company’s initiatives, (21) development and introduction of new products and distribution opportunities, (22) execution of the Company’s entry into new markets, (23) integration of acquired blocks of business and entities, (24) interruption or failure of the Company’s telecommunication, information technology, or other operational systems, or the Company’s failure to maintain adequate security to protect the confidentiality or privacy of personal or sensitive data and intellectual property stored on such systems, (25) adverse developments with respect to litigation, arbitration, or regulatory investigations or actions, (26) the adequacy of reserves, resources and accurate information relating to settlements, awards, and terminated and discontinued lines of business, (27) changes in laws, regulations, and accounting standards applicable to the Company or its business, including Long-Duration Targeted Improvement accounting changes, and (28) other risks and uncertainties described in this document and in the Company’s other filings with the Securities and Exchange Commission (“SEC”).

Forward-looking statements should be evaluated together with the many risks and uncertainties that affect the Company’s business, including those mentioned in this document and described in the periodic reports the Company files with the SEC. These forward-looking statements speak only as of the date on which they are made. The Company does not undertake any obligation to update these forward-looking statements, even though the Company’s situation may change in the future, except as required under applicable securities law. For a discussion of the risks and uncertainties that could cause actual results to differ materially from those contained in the forward-looking statements, you are advised to see Item 1A – “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, as may be supplemented by Item 1A – “Risk Factors” in the Company’s subsequent Quarterly Reports on Form 10-Q and in our other periodic and current reports filed with the SEC.

Overview

The Company is among the leading global providers of life reinsurance and financial solutions, with $3.8 trillion of life reinsurance in force and assets of $109.9 billion as of June 30, 2024. Traditional reinsurance includes individual and group life and health, disability, and critical illness reinsurance. Financial Solutions includes longevity reinsurance, asset-intensive reinsurance, capital solutions, including financial reinsurance and stable value products. The Company derives revenues primarily from renewal premiums from existing reinsurance treaties, new business premiums from existing or new reinsurance treaties, fee income from Financial Solutions business and income earned on invested assets.

The Company’s Traditional business involves reinsuring life insurance policies that are often in force for the remaining lifetime of the underlying individuals insured, with premiums earned typically over a period of 10 to 30 years. To a lesser extent, the Company also reinsures health business typically reinsured for one to three years. Each year, however, a portion of the business under existing treaties terminates due to, among other things, lapses or voluntary surrenders of underlying policies, deaths of insureds, and the exercise of recapture options by ceding companies. The Company’s Financial Solutions business, includes significant asset-intensive and longevity risk transactions, which allow its clients to take advantage of growth opportunities and manage their capital, longevity and investment risk. The Company also works with partners to provide pension plan sponsors solutions that enable them to diversify and protect the benefits provided to the annuitants.

For its traditional business, the Company’s profitability largely depends on the volume and amount of death- and health-related claims incurred and the ability to adequately price the risks it assumes. While death claims are reasonably predictable over a period of many years, claims become less predictable over shorter periods and are subject to significant fluctuation from quarter to quarter and year to year. For longevity business, the Company’s profitability depends on the lifespan of the underlying contract holders and the investment performance for certain contracts. Additionally, the Company generates profits on investment spreads associated with the reinsurance of investment type contracts and generates fees from financial reinsurance transactions, which are typically shorter duration than its traditional life reinsurance business. The Company believes its sources of liquidity are sufficient to cover potential claims payments on both a short-term and long-term basis.

As is customary in the reinsurance business, clients continually update, refine, and revise reinsurance information provided to the Company. Such revised information is used by the Company in preparation of its condensed consolidated financial statements and the financial effects resulting from the incorporation of revised data are reflected in the current period.

Segment Presentation

The Company has geographic-based and business-based operational segments. Geographic-based operations are further segmented into Traditional and Financial Solutions businesses. The Company allocates capital to its segments based on an internally developed economic capital model, the purpose of which is to measure the risk in the business and to provide a consistent basis upon which capital is deployed. The economic capital model considers the unique and specific nature of the risks inherent in RGA’s businesses.

As a result of the economic capital allocation process, a portion of investment income is credited to the segments based on the level of allocated capital. In addition, the segments are charged for excess capital utilized above the allocated economic capital basis. This charge is included in policy acquisition costs and other insurance expenses. Segment investment performance varies with the composition of investments and the relative allocation of capital to the operating segments.

Segment revenue levels can be significantly influenced by currency fluctuations, large transactions, mix of business and reporting practices of ceding companies, and therefore may fluctuate from period to period. Although reasonably predictable over a period of years, segment claims experience can be volatile over shorter periods. See “Results of Operations by Segment” below for further information about the Company’s segments.

Consolidated Results of Operations

Results from Operations – 2024 compared to 2023

The following table summarizes net income for the periods presented.

(Dollars in millions, except per share data)

Revenues Three months ended June 30, 2024 2023 2024 vs 2023 Six months ended June 30, 2024 2023 2024 vs 2023
Net premiums $3,920 $3,337 $583 $9,296 $6,722 $2,574
Net investment income 1,082 857 225 2,043 1,713 330
Investment related losses, net (271) (123) (148) (420) (200) (220)
Other revenues 147 85 62 296 172 124
Total revenues 4,878 4,156 722 11,215 8,407 2,808
Benefits and expenses
Claims and other policy benefits 3,712 3,013 699 8,844 6,076 2,768
Future policy benefits remeasurement (gains) losses (90) 13 (103) (114) (13) (101)
Market risk benefits remeasurement (gains) losses (8) (31) 23 (43) (17) (26)
Interest credited 231 209 22 485 424 61
Policy acquisition costs and other insurance expenses 391 349 42 778 680 98
Other operating expenses 301 275 26 584 525 59
Interest expense 72 63 9 140 116 24
Total benefits and expenses 4,609 3,891 718 10,674 7,791 2,883
Income before income taxes 269 265 4 541 616 (75)
Provision for income taxes 65 58 7 125 156 (31)
Net income $204 $207 $(3) $416 $460 $(44)
Net income attributable to noncontrolling interest 1 2 (1) 3 3 —
Net income available to RGA, Inc. shareholders $203 $205 $(2) $413 $457 $(44)
Earnings per share
Basic earnings per share $3.07 $3.09 $(0.02) $6.28 $6.86 $(0.58)
Diluted earnings per share $3.03 $3.05 $(0.02) $6.19 $6.77 $(0.58)

Three months ended June 30, 2024 compared to three months ended June 30, 2023

The slight decrease in income for the three months ended June 30, 2024, was primarily the result of:

  • An increase in investment related losses resulting from portfolio repositioning and an increase in losses on freestanding derivatives, primarily related to foreign currency and interest rate derivatives.
  • Unfavorable claims experience in the Canada and EMEA Traditional segments.
  • The increases in claims and other policy benefits and investment related losses were partially offset by an increase in net investment income attributable to an increase in average asset base and higher interest rates on new investments, favorable impacts of in force management actions and higher surrender charges and market value adjustments related to higher lapses on a single premium annuity block of business.

Six months ended June 30, 2024 compared to six months ended June 30, 2023

The decrease in income for the six months ended June 30, 2024, was primarily the result of:

  • Unfavorable results in the U.S. Financial Solutions business as a result of a non-economic loss recognized at the inception of a single premium pension risk transfer (“PRT”) transaction completed in first quarter of 2024. The non-economic loss at inception is the difference between the single premium received and the valuation of the initial reserve based on interest rates prescribed by U.S. GAAP.
  • An increase in investment related losses resulting from portfolio repositioning.
  • The increases in claims and other policy benefits and investment related losses were partially offset by an increase in net investment income attributable to an increase in average asset base and higher interest rates on new investments, favorable impacts of in force management actions and higher surrender charges and market value adjustments related to higher lapses on a single premium annuity block of business.

Foreign currency fluctuations can result in variances in the financial statement line items. Foreign currency exchange fluctuations increased income before taxes for the three and six months ended June 30, 2024, by $5 million and $11 million, respectively, primarily due to the weakening of the Japanese Yen compared to the U.S. dollar. Unless otherwise stated, all amounts discussed below are net of foreign currency fluctuations.

Premiums and business growth

The increase in premiums for the three and six months ended June 30, 2024, was primarily due to single premium pension risk transfer (“PRT”) transactions. The PRT single premiums received were offset by an increase in reserves. The remaining increase in premiums for the three and six months ended June 30, 2024, was attributable to organic growth on existing treaties and new business production, measured by the face amount of life reinsurance in force, of $198.7 billion and $168.8 billion during the six months ended June 30, 2024 and 2023, respectively. Consolidated assumed life reinsurance in force increased to $3,767.7 billion as of June 30, 2024, from $3,479.6 billion as of June 30, 2023, primarily due to new business production.

Net investment income and investment related gains (losses), net

The increase in net investment income was primarily attributable to an increase in the average invested asset base and interest rates earned on new investments, partially offset by a decrease in variable investment income associated with joint venture and limited partnership investments:

  • The average invested assets at amortized cost, excluding spread related business, totaled $38.1 billion and $35.8 billion in 2024 and 2023, respectively.
  • The average yield earned on investments, excluding spread related business, was 4.65% and 4.42% for the three month periods ended June 30, 2024 and 2023, respectively, and 4.67% and 4.56% for the six months ended June 30, 2024 and 2023, respectively. The increase in yield for the three and six months ended June 30, 2024, compared to the prior year was attributable to higher new money rates.

The average yield will vary from period to period depending on several variables, including the prevailing risk-free interest rate and credit spread environment, prepayment fees and make-whole premiums, changes in the mix of the underlying investments and cash and cash equivalents balances. Variable investment income from joint ventures and limited partnerships will also vary from period to period and is highly dependent on the timing of dividends and distributions on certain investments. Investment income is allocated to the operating segments based upon average assets and related capital levels deemed appropriate to support segment operations.

The increase in investment related losses, net was primarily attributable to the following:

  • During the three and six months ended June 30, 2024, the Company repositioned its portfolio generating net capital losses of $162 million and $264 million, respectively, compared to net capital losses of $26 million and $70 million during the three and six months ended June 30, 2023, respectively.
  • The Company uses various derivative instruments such as interest rate swaps, credit default swaps and foreign exchange forwards for risk management purposes that either do not qualify or have not been elected for hedge accounting treatment. Changes in the fair value of these instruments are included in investment related gains (losses), net. During the three and six months ended June 30, 2024, the fair value of these instruments decreased by $119 million and $218 million, respectively, compared to decreases of $93 million and $124 million during the first three and six months of 2023. See Note 11 – “Derivative Instruments” for additional information.
  • During the three and six months ended June 30, 2024, the Company incurred $17 million and $37 million of impairments and change in allowance for credit losses on fixed maturity securities compared to $(4) million and $39 million during the three and six months of 2023.
  • The increases in investment related losses were partially offset by the following:
  • Changes in the fair value of embedded derivatives associated with modco/funds withheld treaties decreased investment related losses by $26 million and $103 million for the three and six months ended June 30, 2024, respectively, compared to $(20) million and $17 million for the three and six months ended June 30, 2023, respectively.

The effective tax rate was 24.3% and 23.1% for the three and six months ended June 30, 2024, respectively, compared to 21.7% and 25.2% for the three and six months ended June 30, 2023. See Note 13 – “Income Tax” for additional information on the Company’s consolidated effective tax rate.

Impact of certain derivatives, market risk benefits and non-economic changes in insurance liabilities on income before taxes

The Company recognizes in consolidated income any changes in the fair value of embedded derivatives on modco or funds withheld treaties and non-economic changes in insurance liabilities, such as the initial loss on PRT transactions, and changes in the fair value of embedded derivatives associated with equity index annuities (“EIAs”). In addition, the Company recognizes the changes in fair value of market risk benefits associated with guaranteed minimum benefit riders in market risk benefits remeasurement gains (losses). The Company utilizes freestanding derivatives to minimize the income statement volatility due to changes in the fair value of market risk benefits associated with guaranteed minimum benefit riders. The following table presents the effect of embedded derivatives, market risk benefits, related freestanding derivatives and non-economic changes in insurance liabilities on income before income taxes for the periods indicated (dollars in millions):

Modco/Funds withheld: Three months ended June 30, 2024 2023 2024 vs. 2023 Six months ended June 30, 2024 2023 2024 vs. 2023
Change in fair value of funds withheld embedded derivatives $26 $(20) $46 $103 $17 $86
Non-economic changes in insurance liabilities 9 (2) 11 (127) (4) (123)
Market Risk Benefits:
Market risk benefits remeasurement gains (losses) 8 31 (23) 43 17 26
Related freestanding derivatives (8) (42) 34 (52) (42) (10)
Net effect — (11) 11 (9) (25) 16
Total net effect after freestanding derivatives $35 $(33) $68 $(33) $(12) $(21)

56

Results of Operations by Segment

U.S. and Latin America Operations

The U.S. and Latin America operations consist of two major segments: Traditional and Financial Solutions. The Traditional segment primarily specializes in the reinsurance of individual mortality-risk, health and long-term care and to a lesser extent, group reinsurance. The Financial Solutions segment consists of asset-intensive and capital solutions. Asset-intensive includes coinsurance of annuities, corporate-owned life insurance policies, pension risk transfer (“PRT”) group annuity contracts and, to a lesser extent, fee-based synthetic guaranteed investment contracts, which include investment-only, stable value contracts. Capital solutions includes assisting ceding companies in meeting applicable regulatory requirements by enhancing the ceding companies’ financial strength and regulatory surplus position through relatively low risk reinsurance and other transactions. Typically, these transactions do not qualify as reinsurance under GAAP due to the low-risk nature of the transactions; therefore, only the related net fees are reflected in other revenues on the condensed consolidated statements of income.

The following table summarizes income before income taxes for the Company’s U.S. and Latin America operations for the periods presented:

(dollars in millions)

Revenues Three months ended June 30, 2024 2023 2024 vs 2023 Six months ended June 30, 2024 2023 2024 vs 2023
Net premiums $2,132 $1,767 $365 $5,763 $3,545 $2,218
Net investment income 522 458 64 1,031 932 99
Investment related gains (losses), net (9) (69) 60 6 (50) 56
Other revenues 63 54 9 131 110 21
Total revenues 2,708 2,210 498 6,931 4,537 2,394
Benefits and expenses
Claims and other policy benefits 2,041 1,637 404 5,692 3,283 2,409
Future policy benefits remeasurement (gains) losses (69) 23 (92) (88) 26 (114)
Market risk benefits remeasurement (gains) losses (8) (31) 23 (43) (17) (26)
Interest credited 139 151 (12) 306 298 8
Policy acquisition costs and other insurance expenses 273 236 37 528 459 69
Other operating expenses 75 64 11 146 123 23
Total benefits and expenses 2,451 2,080 371 6,541 4,172 2,369
Income before income taxes $257 $130 $127 $390 $365 $25

The increase in income before income taxes for the second quarter was primarily due to favorable impacts of in-force management actions in the Traditional segment and higher net investment income. The increase in income before income taxes for the first six months of 2024 was primarily due to favorable impacts of in-force management actions in the Traditional segment and favorable net investment income, partially offset by the net impact of certain derivatives, market risk benefits and non-economic change in insurance liabilities in the Financial Solutions segment. The non-economic change in insurance liabilities was primarily related to the initial loss recognized at the inception of a single premium PRT transaction completed in the first quarter of 2024. The non-economic loss at inception is the difference between the single premium received and the valuation of the initial reserve based on interest rates prescribed by U.S. GAAP.

Traditional Reinsurance

(dollars in millions)

Revenues Three months ended June 30, 2024 2023 2024 vs 2023 Six months ended June 30, 2024 2023 2024 vs 2023
Net premiums $1,827 $1,750 $77 $3,542 $3,365 $177
Net investment income 203 180 23 408 373 35
Investment related gains (losses), net 6 (1) 7 (6) (2) (4)
Other revenues 8 3 5 14 8 6
Total revenues 2,044 1,932 112 3,958 3,744 214
Benefits and expenses
Claims and other policy benefits 1,676 1,592 84 3,248 3,039 209
Future policy benefits remeasurement (gains) losses (66) 24 (90) (87) 31 (118)
Market risk benefits remeasurement (gains) losses — — — — — —
Interest credited 19 18 1 38 36 2
Policy acquisition costs and other insurance expenses 186 187 (1) 361 362 (1)
Other operating expenses 55 49 6 108 93 15
Total benefits and expenses 1,870 1,870 — 3,668 3,561 107
Income before income taxes $174 $62 $112 $290 $183 $107
Key metrics
Life reinsurance in force $1,716.1 billion $1,685.3 billion
Future policy benefits remeasurement (gains) losses
Effect of changes in cash flow assumptions $— $— $— $—
Effect of actual variances from expected experience $(66) $24 $(87) $31
Loss ratio (1) 88.1% 92.3% 89.2% 91.2%
Policy acquisition costs and other insurance expenses as a percentage of net premiums 10.2% 10.7% 10.2% 10.8%
Other operating expenses as a percentage of net premiums 3.0% 2.8% 3.0% 2.8%

(1) Includes Claims and other policy benefits and Future policy benefits remeasurement (gains) losses

The increase in income before income taxes for the second quarter and the first six months of 2024 was primarily the result of favorable impacts of in-force management actions and higher net investment income.

Revenues

  • The increase in net premiums was primarily due to organic growth and new business treaties, as well as the recapture of a large retrocession treaty, effective April 1, 2023. The segment added new life business production, measured by face amount of life reinsurance in force, of $76.9 billion and $69.7 billion during the first six months of 2024 and 2023, respectively.
  • The increase in net investment income during the three and six months ended June 30, 2024, was primarily due to a higher invested asset base in 2024 due to new business growth.
  • The increase in future policy benefits remeasurement gains for the second quarter and first six months of 2024 was attributable to favorable impacts of in-force management actions, as well as claims experience period over period, primarily within the U.S. Individual Life business.
  • The slight decrease in policy acquisition costs and other insurance expenses as a percentage of net premiums was primarily due to varying allowance levels within coinsurance type arrangements and the mix of new business between coinsurance versus yearly renewable term.

Financial Solutions

(dollars in millions)

Revenues Three months ended June 30, 2024 2023 2024 vs 2023 Six months ended June 30, 2024 2023 2024 vs 2023
Net premiums $305 $17 $288 $2,221 $180 $2,041
Net investment income 319 278 41 623 559 64
Investment related gains (losses), net (15) (68) 53 12 (48) 60
Other revenues 55 51 4 117 102 15
Total revenues 664 278 386 2,973 793 2,180
Benefits and expenses
Claims and other policy benefits 365 45 320 2,444 244 2,200
Future policy benefits remeasurement (gains) losses (3) (1) (2) (1) (5) 4
Market risk benefits remeasurement (gains) losses (8) (31) 23 (43) (17) (26)
Interest credited 120 133 (13) 268 262 6
Policy acquisition costs and other insurance expenses 87 49 38 167 97 70
Other operating expenses 20 15 5 38 30 8
Total benefits and expenses 581 210 371 2,873 611 2,262
Income before income taxes $83 $68 $15 $100 $182 $(82)

The increase in income before income taxes for the U.S. and Latin America Financial Solutions segment for the three months ended June 30, 2024, was driven by the net impact of certain derivatives, market risk benefits and non-economic changes in insurance liabilities, offset by increases in investment related losses. The decrease in income before income taxes for the six months ended June 30, 2024, was due to increases in investment related losses, the decline in the invested asset base, and the non-economic changes in insurances liabilities, partially offset by the net impact of certain derivatives and market risk benefits.

The invested asset base supporting asset-intensive transactions decreased to $22.1 billion as of June 30, 2024, from $22.7 billion as of June 30, 2023.

  • The decrease in the asset base was primarily due to $2.3 billion in net run off of existing in-force transactions and $2.4 billion associated with an in-force retrocession transaction partially offset by $4.1 billion from new transactions.
  • As of June 30, 2024 and 2023, $3.5 billion and $3.9 billion, respectively, of the invested assets were funds withheld at interest, of which greater than 90% was associated with two clients.

As of June 30, 2024 and 2023, the amount of reinsurance assumed in capital solutions transactions, as measured by pre-tax statutory surplus, risk based capital and other financial structures was $29.5 billion and $25.6 billion, respectively.

Impact of certain derivatives, market risk benefits and non-economic changes in insurance liabilities

Income from the Financial Solutions business tends to be volatile due to the impact of certain items such as changes in the fair value of certain derivatives, including embedded derivatives associated with reinsurance treaties structured on a modco or funds withheld basis, non-economic changes in insurance liabilities, which include the initial loss on PRT transactions, changes in the fair value of embedded derivatives associated with the Company’s reinsurance of EIAs, and changes in the fair value of market risk benefits associated with guaranteed minimum benefit riders. Fluctuations occur period to period primarily due to changing investment conditions including, but not limited to, interest rate movements (including risk-free rates and credit spreads), implied volatility and equity market performance, all of which are factors in the calculations of the fair value of the assets and liabilities.

The following table summarizes the U.S. and Latin America Financial Solutions results and quantifies the impact of these embedded derivatives, market risk benefits and non-economic changes in insurance liabilities for the periods presented. Revenues before the impact of certain items should not be viewed as substitutes for GAAP revenues, GAAP benefits and expenses and GAAP income before income taxes.

(dollars in millions)

Revenues Three months ended June 30, 2024 2023 2024 vs 2023 Six months ended June 30, 2024 2023 2024 vs 2023
Total revenues $664 $278 $386 $2,973 $793 $2,180
Less:
Embedded derivatives – modco/funds withheld treaties 20 (19) 39 109 19 90
Derivatives hedging market risk benefits (8) (42) 34 (52) (40) (12)
Revenues before impact of certain items 652 339 313 2,916 814 2,102
Benefits and expenses
Total benefits and expenses 581 210 371 2,873 611 2,262
Less:
Non-economic changes in insurance liabilities (9) 2 (11) 127 4 123
Market risk benefits remeasurement (gains) losses (8) (31) 23 (43) (18) (25)
Benefits and expenses before impact of certain items 598 239 359 2,789 625 2,164
Income before income taxes:
Income before income taxes 83 68 15 100 182 (82)
Less:
Embedded derivatives – modco/funds withheld treaties 20 (19) 39 109 19 90
Non-economic changes in insurance liabilities 9 (2) 11 (127) (4) (123)
Market risk benefits remeasurement (gains) losses and related freestanding derivatives — (11) 11 (9) (22) 13
Income before income taxes and certain items $54 $100 $(46) $127 $189 $(62)

Embedded Derivatives – Modco/Funds Withheld Treaties – Represents the change in the fair value of embedded derivatives on funds withheld at interest associated with treaties written on a modco or funds withheld basis. The Company’s utilization of a credit valuation adjustment did not have a material effect on the change in fair value of these embedded derivatives for the three and six months ended June 30, 2024 and 2023.

The change in fair value of the embedded derivatives related to modco/funds withheld treaties increased (decreased) income before income taxes by $20 million and $(19) million for the second quarter and $109 million and $19 million for the six months ended June 30, 2024 and 2023, respectively. The increase in income for the three months ended June 30, 2024, was due to tightening credit spreads. The decrease in income for the three months ended June 30, 2023, was due to widening credit spreads. The increase in income for the six months ended June 30, 2024, was due to increased interest rates on funds withheld liabilities. The increase in income for the six months ended June 30, 2023, was due to tightening credit spreads on funds withheld asset balances and the impact of higher risk-free interest rates on funds withheld liabilities balances.

Non-Economic Changes in Insurance Liabilities – Non-economic changes in insurance liabilities include the initial loss on PRT transactions, net of amortization, and changes in the fair value of embedded derivatives associated with the Company’s reinsurance of EIAs. The initial loss at inception of a PRT transaction is the difference between the single premium received and the valuation of the initial reserve based on interest rates prescribed by U.S. GAAP.

Market Risk Benefits – Represents the impact related to market risk benefits, which consist of guaranteed minimum benefits associated with the Company’s reinsurance of variable and equity-indexed annuities. The fair value changes of market risk benefits along with the changes in fair value of the freestanding derivatives (interest rate swaps, financial futures and equity options) purchased by the Company to substantially hedge the liability are reflected in revenues. The change in fair value of market risk benefits for guaranteed minimum benefits, after allowing for changes in the associated freestanding derivatives, had no impact on income before income taxes for the three months ended June 30, 2024, and decreased income before income taxes by $9 million for the six months ended June 30, 2024. The changes in fair value of the market risk benefits decreased income before income taxes by $11 million and $22 million for the three and six months ended June 30, 2023, respectively.

Discussion and analysis before certain derivatives, market risk benefits and non-economic changes in insurance liabilities

The impact of certain derivatives, market risk benefits and non-economic changes in insurance liabilities discussed above are considered unrealized and non-economic by management and do not affect current cash flows, crediting rates or performance on the underlying treaties. Fluctuations occur period to period primarily due to changing investment conditions including, but not limited to, interest rate movements (including benchmark rates and credit spreads), implied volatility and equity market performance, all of which are factors in the calculations of fair value. Therefore, management believes it is helpful to distinguish between the effects of these items and the primary factors that drive profitability of the underlying treaties, which are investment income, fee income (included in other revenues) and interest credited.

  • Income before income taxes and certain items decreased by $46 million and $62 million for the three and six months ended June 30, 2024, as compared to the same periods in 2023, primarily due to increases in realized investment related losses and the decline in the invested asset base.
  • Revenue before certain items increased by $313 million and $2,102 million for the three and six months ended June 30, 2024, as compared to the same periods in 2023. The increase was primarily due to premiums recognized on PRT transactions, which was offset by a corresponding increase in reserves.
  • Benefits and expenses before certain items increased by $359 million and $2,164 million for the three and six months ended June 30, 2024, as compared to the same periods in 2023. The increase was primarily due to the establishment of liabilities for future policy benefits associated with PRT transactions.

Canada Operations

The Canada operations are primarily engaged in traditional reinsurance, which consists mainly of traditional individual life reinsurance, and to a lesser extent, creditor, group life and health, critical illness and disability reinsurance. Creditor insurance covers the outstanding balance on personal, mortgage or commercial loans in the event of death, disability or critical illness and is generally shorter in duration than traditional individual life insurance. The Canada Financial Solutions segment consists of longevity and capital solutions.

(dollars in millions)

Revenues Three months ended June 30, 2024 2023 2024 vs 2023 Six months ended June 30, 2024 2023 2024 vs 2023
Net premiums $374 $330 $44 $715 $648 $67
Net investment income 109 62 47 174 124 50
Investment related gains (losses), net — 4 (4) 1 6 (5)
Other revenues 7 3 4 13 7 6
Total revenues 490 399 91 903 785 118
Benefits and expenses
Claims and other policy benefits 393 302 91 695 593 102
Future policy benefits remeasurement (gains) losses 1 (3) 4 (2) (5) 3
Market risk benefits remeasurement (gains) losses — — — — — —
Interest credited — — — — — —
Policy acquisition costs and other insurance expenses 50 47 3 98 93 5
Other operating expenses 13 12 1 25 24 1
Total benefits and expenses 457 358 99 816 705 111
Income before income taxes $33 $41 $(8) $87 $80 $7

The decrease in income before income taxes for the three months ended June 30, 2024, was primarily due to lower investment related gains and future policy benefits remeasurement losses as compared to future policy benefits remeasurement gains in the second quarter of 2023. The increase in income before income taxes for the six months ended June 30, 2024, was primarily due to favorable experience on group business, partially offset by lower future policy remeasurement gains and investment related gains.

For the three and six months ended June 30, 2024, the increases in net premiums, net investment income, other revenues, claims and other policy benefits and policy acquisition costs and other insurance expenses were due to a new financial solutions transaction executed in the second quarter of 2024.

Foreign currency fluctuations can result in variances in the financial statement line items. Foreign currency fluctuations did not impact income before income taxes for the three and six months ended June 30, 2024. Unless otherwise stated, all amounts discussed below are net of foreign currency fluctuations.

Traditional Reinsurance

(dollars in millions)

Revenues Three months ended June 30, 2024 2023 2024 vs 2023 Six months ended June 30, 2024 2023 2024 vs 2023
Net premiums $326 $307 $19 $644 $602 $42
Net investment income 61 61 — 125 122 3
Investment related gains (losses), net 1 4 (3) 2 6 (4)
Other revenues 1 1 — 4 2 2
Total revenues 389 373 16 775 732 43
Benefits and expenses
Claims and other policy benefits 304 282 22 587 552 35
Future policy benefits remeasurement (gains) losses 1 (1) 2 (2) 2 (4)
Market risk benefits remeasurement (gains) losses — — — — — —
Interest credited — — — — — —
Policy acquisition costs and other insurance expenses 46 47 (1) 93 92 1
Other operating expenses 11 10 1 23 22 1
Total benefits and expenses 362 338 24 701 668 33
Income before income taxes $27 $35 $(8) $74 $64 $10
Key metrics
Life reinsurance in force $489.3 billion $484.6 billion
Future policy benefits remeasurement (gains) losses
Effect of changes in cash flow assumptions $— $— $— $—
Effect of actual variances from expected experience $1 $(1) $(2) $2
Loss ratio (1) 93.6% 91.5% 90.8% 92.0%
Policy acquisition costs and other insurance expenses as a percentage of net premiums 14.1% 15.3% 14.4% 15.3%
Other operating expenses as a percentage of net premiums 3.4% 3.3% 3.6% 3.7%

(1) Includes Claims and other policy benefits and Future policy benefits remeasurement (gains) losses

The decrease in income before income taxes for the three months ended June 30, 2024, was primarily due to lower investment related gains and future policy remeasurement losses as compared to future policy remeasurement gains in the second quarter of 2023. The increase in income before income taxes for the six months ended June 30, 2024, was primarily due to favorable experience on group business and future policy benefits remeasurement gains as compared to future policy benefits remeasurement losses in 2023, partially offset by lower investment related gains.

Revenues

  • The increase in net premiums for the three and six months ended June 30, 2024, was primarily due to new group business and organic growth on all lines of business.
  • The segment added new life business production, measured by face amount of life reinsurance in force, of $23.8 billion and $22.0 billion during the first six months of 2024 and 2023, respectively.
  • The increase in net investment income in the first six months of 2024 was primarily due to an increase in the invested asset base.
  • The increase in the loss ratio for the second quarter was primarily due to unfavorable claims experience in the individual life line of business and higher future policy remeasurement losses as compared to the same period in 2023. The decrease in the loss ratio for the six months ended June 30, 2024 was primarily due to favorable experience on group line of business and future policy benefits remeasurement gains as compared to future policy benefits remeasurement losses in 2023.

Financial Solutions

(dollars in millions)

Revenues Three months ended June 30, 2024 2023 2024 vs 2023 Six months ended June 30, 2024 2023 2024 vs 2023
Net premiums $48 $23 $25 $71 $46 $25
Net investment income 48 1 47 49 2 47
Investment related gains (losses), net (1) — (1) (1) — (1)
Other revenues 6 2 4 9 5 4
Total revenues 101 26 75 128 53 75
Benefits and expenses
Claims and other policy benefits 89 20 69 108 41 67
Future policy benefits remeasurement (gains) losses — (2) 2 — (7) 7
Market risk benefits remeasurement (gains) losses — — — — — —
Interest credited — — — — — —
Policy acquisition costs and other insurance expenses 4 — 4 5 1 4
Other operating expenses 2 2 — 2 2 —
Total benefits and expenses 95 20 75 115 37 78
Income before income taxes $6 $6 $— $13 $16 $(3)
Key metrics
Future policy benefits remeasurement (gains) losses
Effect of changes in cash flow assumptions $— $— $— $—
Effect of actual variances from expected experience $— $(2) $— $(7)

Income before income taxes remained consistent for the second quarter of 2024 as compared to the same period in 2023. The decrease in income before income taxes for the six months ended June 30, 2024, compared to the same period in 2023, was due to a decrease in future policy benefits remeasurement gains. For the three and six months ended June 30, 2024, the increases in net premiums, net investment income, other revenues, claims and other policy benefits and policy acquisition costs and other insurance expenses were due to a new transaction executed in the second quarter of 2024.

Europe, Middle East and Africa Operations

The Europe, Middle East and Africa (“EMEA”) operations consists of two major segments: Traditional and Financial Solutions. The Traditional segment primarily provides reinsurance through yearly renewable term and coinsurance agreements on a variety of life, health and critical illness products. Reinsurance agreements may be facultative or automatic agreements covering primarily individual risks and, in some markets, group risks. The Financial Solutions segment consists of reinsurance and other transactions associated with longevity closed blocks, payout annuities, capital management solutions and financial reinsurance.

(dollars in millions)

Revenues Three months ended June 30, 2024 2023 2024 vs 2023 Six months ended June 30, 2024 2023 2024 vs 2023
Net premiums $656 $519 $137 $1,298 $1,082 $216
Net investment income 104 68 36 200 137 63
Investment related gains (losses), net (12) (9) (3) (27) (15) (12)
Other revenues 8 3 5 21 6 15
Total revenues 756 581 175 1,492 1,210 282
Benefits and expenses
Claims and other policy benefits 597 451 146 1,143 945 198
Future policy benefits remeasurement (gains) losses 8 7 1 5 (10) 15
Market risk benefits remeasurement (gains) losses — — — — — —
Interest credited 8 (2) 10 14 (2) 16
Policy acquisition costs and other insurance expenses 24 23 1 63 43 20
Other operating expenses 46 46 — 102 92 10
Total benefits and expenses 683 525 158 1,327 1,068 259
Income before income taxes $73 $56 $17 $165 $142 $23

The increase in income before income taxes for the three and six months ended June 30, 2024, as compared to the same periods in 2023, was primarily due to increased net premiums and net investment income, partially offset by increased claims and other policy benefits and increased policy acquisition costs and other insurance expenses.

Foreign currency fluctuations can result in variances in the financial statement line items. Foreign currency fluctuations did not impact income before income taxes for the three months ended June 30, 2024, and resulted in a $3 million increase in income before income taxes for the six months ended June 30, 2024. Unless otherwise stated, all amounts discussed below are net of foreign currency fluctuations.

Traditional Reinsurance

(dollars in millions)

Revenues Three months ended June 30, 2024 2023 2024 vs 2023 Six months ended June 30, 2024 2023 2024 vs 2023
Net premiums $497 $429 $68 $993 $867 $126
Net investment income 27 23 4 54 46 8
Investment related gains (losses), net — — — — — —
Other revenues — (1) 1 2 (2) 4
Total revenues 524 451 73 1,049 911 138
Benefits and expenses
Claims and other policy benefits 464 383 81 888 773 115
Future policy benefits remeasurement (gains) losses 6 12 (6) 1 4 (3)
Market risk benefits remeasurement (gains) losses — — — — — —
Interest credited — — — — — —
Policy acquisition costs and other insurance expenses 22 21 1 59 39 20
Other operating expenses 31 31 — 72 64 8
Total benefits and expenses 523 447 76 1,020 880 140
Income before income taxes $1 $4 $(3) $29 $31 $(2)
Key metrics
Life reinsurance in force $976.5 billion $802.3 billion
Future policy benefits remeasurement (gains) losses
Effect of changes in cash flow assumptions $— $— $— $—
Effect of actual variances from expected experience $6 $12 $1 $4
Loss ratio (1) 94.6% 92.1% 89.5% 89.6%
Policy acquisition costs and other insurance expenses as a percentage of net premiums 4.4% 4.9% 5.9% 4.5%
Other operating expenses as a percentage of net premiums 6.2% 7.2% 7.3% 7.4%

(1) Includes Claims and other policy benefits and Future policy benefits remeasurement (gains) losses

The decreases in income before income taxes for the three and six months ended June 30, 2024, as compared to the same periods in 2023, were primarily due to unfavorable claims and other policy benefits and increased policy acquisition costs and other insurance expenses, largely offset by increased net premiums.

Revenues

  • The increases in net premiums for the three and six months ended June 30, 2024, were primarily due to increased business volume on new and existing treaties.
  • The segment added new life business production, measured by face amount of life reinsurance in force, of $58.0 billion and $66.7 billion during the six months ended June 30, 2024 and 2023, respectively.
  • The increase in the loss ratios for the second quarter was primarily due to unfavorable mortality and morbidity claims experience.
  • The decrease in policy acquisition costs and other insurance expenses as a percentage of net premiums for the second quarter was largely due to an increase in premiums with lower allowances. The increase in policy acquisition costs and other insurance expenses as a percentage of net premiums in the first six months of 2024 as compared to the same period in 2023 was primarily due to an increase in premiums with higher allowances.

Financial Solutions

(dollars in millions)

Revenues Three months ended June 30, 2024 2023 2024 vs 2023 Six months ended June 30, 2024 2023 2024 vs 2023
Net premiums $159 $90 $69 $305 $215 $90
Net investment income 77 45 32 146 91 55
Investment related gains (losses), net (12) (9) (3) (27) (15) (12)
Other revenues 8 4 4 19 8 11
Total revenues 232 130 102 443 299 144
Benefits and expenses
Claims and other policy benefits 133 68 65 255 172 83
Future policy benefits remeasurement (gains) losses 2 (5) 7 4 (14) 18
Market risk benefits remeasurement (gains) losses — — — — — —
Interest credited 8 (2) 10 14 (2) 16
Policy acquisition costs and other insurance expenses 2 2 — 4 4 —
Other operating expenses 15 15 — 30 28 2
Total benefits and expenses 160 78 82 307 188 119
Income before income taxes $72 $52 $20 $136 $111 $25
Key metrics
Future policy benefits remeasurement (gains) losses
Effect of changes in cash flow assumptions $— $— $— $—
Effect of actual variances from expected experience $2 $(5) $4 $(14)

The increases in income before income taxes for the three and six months ended June 30, 2024, were primarily due to increases in net investment income and growth in closed longevity business, partially offset by investment related gains (losses) and future policy benefits remeasurement losses.

  • The increase in net premiums for the first six months was primarily due to increased volumes of closed block longevity transactions.
  • The increase in net investment income was primarily related to an increase in invested assets and higher yields from fixed-income securities.
  • The increase in investment related losses was attributable to higher investment related losses on fixed-income security sales associated with portfolio repositioning and fluctuations in the fair market value of CPI swap derivatives due to changes in future inflation expectations.
  • The increase in other revenues was primarily due to new capital solutions business.
  • The increase in claims and other policy benefits was the result of increased volumes of closed block longevity and asset-intensive transactions.

Asia Pacific Operations

The Asia Pacific operations include business generated by its offices throughout Asia and Australia. The Traditional segment’s principal types of reinsurance include individual and group life and health, critical illness, disability and superannuation. Reinsurance agreements may be facultative or automatic agreements covering primarily individual risks, and in some markets, group risks. Superannuation is the Australian government mandated compulsory retirement savings program. Superannuation funds accumulate retirement funds for employees, and, in addition, typically offer life and disability insurance coverage. The Financial Solutions segment includes financial reinsurance, asset-intensive and certain disability and life blocks.

(dollars in millions)

Revenues Three months ended June 30, 2024 2023 2024 vs 2023 Six months ended June 30, 2024 2023 2024 vs 2023
Net premiums $758 $721 $37 $1,520 $1,447 $73
Net investment income 224 187 37 409 356 53
Investment related gains (losses), net (171) (49) (122) (242) (97) (145)
Other revenues 69 29 40 127 42 85
Total revenues 880 888 (8) 1,814 1,748 66
Benefits and expenses
Claims and other policy benefits 681 623 58 1,314 1,255 59
Future policy benefits remeasurement (gains) losses (30) (14) (16) (29) (24) (5)
Market risk benefits remeasurement (gains) losses — — — — — —
Interest credited 49 46 3 100 100 —
Policy acquisition costs and other insurance expenses 72 63 9 142 125 17
Other operating expenses 66 61 5 123 117 6
Total benefits and expenses 838 779 59 1,650 1,573 77
Income before income taxes $42 $109 $(67) $164 $175 $(11)

The decreases in income before taxes for the three and six months ended June 30, 2024, as compared to the same periods in 2023, were primarily due to investment related losses in the Financial Solutions segment.

Foreign currency fluctuations can result in variances in the financial statement line items. Foreign currency fluctuations resulted in increases of $6 million and $8 million in income before income taxes during the three and six months ended June 30, 2024. Unless otherwise stated, all amounts discussed below are net of foreign currency fluctuations.

Traditional Reinsurance

(dollars in millions)

Revenues Three months ended June 30, 2024 2023 2024 vs 2023 Six months ended June 30, 2024 2023 2024 vs 2023
Net premiums $708 $677 $31 $1,424 $1,339 $85
Net investment income 61 62 (1) 126 123 3
Investment related gains (losses), net 1 2 (1) 1 5 (4)
Other revenues 8 11 (3) 18 14 4
Total revenues 778 752 26 1,569 1,481 88
Benefits and expenses
Claims and other policy benefits 607 579 28 1,193 1,142 51
Future policy benefits remeasurement (gains) losses (29) (14) (15) (28) (23) (5)
Market risk benefits remeasurement (gains) losses — — — — — —
Interest credited — — — — — —
Policy acquisition costs and other insurance expenses 42 44 (2) 87 90 (3)
Other operating expenses 58 54 4 108 104 4
Total benefits and expenses 678 663 15 1,360 1,313 47
Income before income taxes $100 $89 $11 $209 $168 $41
Key metrics
Life reinsurance in force $557.8 billion $495.4 billion
Future policy benefits remeasurement (gains) losses
Effect of changes in cash flow assumptions $— $— $— $—
Effect of actual variances from expected experience $(29) $(14) $(28) $(23)
Loss ratio (1) 81.6% 83.5% 81.8% 83.6%
Policy acquisition costs and other insurance expenses as a percentage of net premiums 5.9% 6.5% 6.1% 6.7%
Other operating expenses as a percentage of net premiums 8.2% 8.0% 7.6% 7.8%

(1) Includes Claims and other policy benefits and Future policy benefits remeasurement (gains) losses

The increases in income before income taxes for the three and six months ended June 30, 2024, were primarily the result of increased net premiums and inforce management actions, partially offset by increased claims and other policy benefits.

Revenues

  • The increases in net premiums were primarily due to continued business growth in the segment.
  • The segment added new life business production, measured by face amount of life reinsurance in force, of $30.7 billion and $8.6 billion during the six months ended June 30, 2024 and 2023, respectively.
  • The decrease in the loss ratio for the three and six months ended June 30, 2024, as compared to the same periods in 2023, was primarily due to business growth and inforce management actions.

Financial Solutions

(dollars in millions)

Revenues Three months ended June 30, 2024 2023 2024 vs 2023 Six months ended June 30, 2024 2023 2024 vs 2023
Net premiums $50 $44 $6 $96 $108 $(12)
Net investment income 163 125 38 283 233 50
Investment related gains (losses), net (172) (51) (121) (243) (102) (141)
Other revenues 61 18 43 109 28 81
Total revenues 102 136 (34) 245 267 (22)
Benefits and expenses
Claims and other policy benefits 74 44 30 121 113 8
Future policy benefits remeasurement (gains) losses (1) — (1) (1) (1) —
Market risk benefits remeasurement (gains) losses — — — — — —
Interest credited 49 46 3 100 100 —
Policy acquisition costs and other insurance expenses 30 19 11 55 35 20
Other operating expenses 8 7 1 15 13 2
Total benefits and expenses 160 116 44 290 260 30
Income (loss) before income taxes $(58) $20 $(78) $(45) $7 $(52)
Key metrics
Future policy benefits remeasurement (gains) losses
Effect of changes in cash flow assumptions $— $— $— $—
Effect of actual variances from expected experience $(1) $— $(1) $(1)

The decreases in income before income taxes during the three and six months ended June 30, 2024, as compared to the same periods in 2023, were driven by increases in investment related losses, partially offset by the impact of higher surrender charges and market value adjustments related to higher lapses on a single premium annuity block of business.

The invested asset base supporting asset-intensive transactions increased to $19.4 billion as of June 30, 2024, from $15.1 billion as of June 30, 2023. The increase in the asset base compared to June 30, 2023, was primarily due to approximately $5.7 billion from recently executed transactions, partially offset by net organic decline of $1.4 billion from existing in force blocks. The amount of reinsurance assumed from client companies, as measured by pre-tax statutory surplus, risk based capital and other financial reinsurance structures was $1.6 billion and $1.1 billion for the six months ended June 30, 2024 and 2023, respectively. Fees earned from this business can vary significantly depending on the size, complexity and timing of the transactions and, therefore, can fluctuate from period to period.

Revenues

  • The increases in net investment income were the result of a growing asset base and improved yields from increased interest rates.
  • The increases in investment related losses, net for the three and six months ended June 30, 2024, as compared to the same periods in 2023 were attributable to net losses from investment activity of $71 million and $41 million, respectively, largely due to portfolio repositioning on recently executed transactions and higher lapses, as well as a decrease in the fair value of derivatives of $50 million and $100 million, respectively, primarily due to the weakening of the Japanese yen.
  • The increases in other revenue for the three and six months ended June 30, 2024, as compared to the same periods in 2023, were driven by surrender charges and market value adjustments due to higher lapses on a single premium annuity block of business.
  • The increases in claims and other policy benefits and policy acquisition costs and other insurance expenses for the three and six months ended June 30, 2024, as compared to the same periods in 2023, were the result of new asset-intensive transactions.

Corporate and Other

Corporate and Other revenues primarily include investment income from unallocated invested assets, investment related gains and losses and service fees. Corporate and Other expenses consist of the offset to capital charges allocated to the operating segments within the policy acquisition costs and other insurance income line item, unallocated overhead and executive costs, interest expense related to debt and service business expenses. Additionally, Corporate and Other includes results from the Company’s Funding Agreement Backed Notes (“FABN”) program and certain wholly-owned subsidiaries that, among other activities, develop and market technology and provide consulting and outsourcing solutions for the insurance and reinsurance industries. The Company invests in this area in an effort to both support its clients and accelerate the development of innovative solutions and services to increase consumer engagement within the life insurance industry and hence generate new future revenue streams.

(dollars in millions)

Revenues Three months ended June 30, 2024 2023 2024 vs 2023 Six months ended June 30, 2024 2023 2024 vs 2023
Net premiums $— $— $— $— $— $—
Net investment income 123 82 41 229 164 65
Investment related gains (losses), net (79) — (79) (158) (44) (114)
Other revenues — (4) 4 4 7 (3)
Total revenues 44 78 (34) 75 127 (52)
Benefits and expenses
Claims and other policy benefits — — — — — —
Future policy benefits remeasurement (gains) losses — — — — — —
Market risk benefits remeasurement (gains) losses — — — — — —
Interest credited 35 14 21 65 28 37
Policy acquisition costs and other insurance expenses (28) (20) (8) (53) (40) (13)
Other operating expenses 101 92 9 188 169 19
Interest expense 72 63 9 140 116 24
Total benefits and expenses 180 149 31 340 273 67
Loss before income taxes $(136) $(71) $(65) $(265) $(146) $(119)

The increase in losses before income taxes for the three and six months ended June 30, 2024, were primarily due to increases in investment related losses, interest credited, other operating expenses and interest expense, partially offset by higher net investment income.

Revenues

  • The increases in net investment income for the three and six months ended June 30, 2024, were the result of higher income on Corporate invested assets due to higher yields and a higher asset base.
  • The increase in investment related losses for the three and six months ended June 30, 2024, was primarily attributable to losses on sales of fixed maturity securities in 2024.

Expenses

  • The increase in interest credited for the three and six months ended June 30, 2024, was primarily attributable to new FABN issuances.
  • The increases in other operating expenses for the three and six months ended June 30, 2024, were primarily attributable to an increase in incentive compensation expense.
  • The increases in interest expense for the three and six months ended June 30, 2024, were primarily attributable to an increase in outstanding debt.

Liquidity and Capital Resources

Overview

The Company believes that cash flows from the source of funds available to it will provide sufficient cash flows for the next twelve months to satisfy the current liquidity requirements of the Company under various scenarios that include the potential risk of early recapture of reinsurance treaties, market events and higher than expected claims. The Company performs periodic liquidity stress testing to ensure its asset portfolio includes sufficient high quality liquid assets that could be utilized to bolster its liquidity position under stress scenarios. These assets could be utilized as collateral for secured borrowing transactions with various third parties or by selling the securities in the open market if needed. The Company’s liquidity requirements have been and will continue to be funded through net cash flows from operations. However, in the event of significant unanticipated cash requirements beyond normal liquidity needs, the Company has multiple liquidity alternatives available based on market conditions and the amount and timing of the liquidity need. These alternatives include the sale of invested assets subject to market conditions, borrowings under committed credit facilities, secured borrowings, and if necessary, issuing long-term debt, preferred securities or common equity.

Current Market Environment

The Company’s average investment yield, excluding spread related business, for the three months ended June 30, 2024, was 4.65%, 23 basis points above the same period in 2023, primarily attributable to higher new money rates. The average yield will vary from year to year depending on several variables, including the prevailing risk-fee interest rate and credit spread environment, prepayment fees and make-whole premiums, changes in the mix of the underlying investments and cash and cash equivalents balances. Variable investment income from joint ventures and limited partnerships will also vary from year to year and is highly dependent on the timing of dividends and distributions on certain investments. Gross unrealized gains on fixed maturity securities available-for-sale decreased from $1.1 billion at December 31, 2023, to $1.0 billion at June 30, 2024. Additionally, gross unrealized losses increased from $5.6 billion at December 31, 2023, to $6.5 billion at June 30, 2024.

The Company continues to be in a position to hold any investment security showing an unrealized loss until recovery, provided it remains comfortable with the credit of the issuer. The Company does not rely on short-term funding or commercial paper and to date it has experienced no liquidity pressure, nor does it anticipate such pressure in the foreseeable future.

The Company projects its reserves to be sufficient and it would not expect to be required to take any actions to augment capital, even if interest rates remain at current levels for the next five years, assuming all other factors remain constant. To mitigate disintermediation risk, the Company purchased swaptions to protect it against a material increase in interest rates. While the Company has felt the pressures of sustained low interest rates, followed by the recent significant increase in risk-free rates, and volatile equity markets, its business and results of operations are not overly sensitive to these risks. Mortality and morbidity risks continue to be the most significant risk for the Company. Although management believes the Company’s current capital base is adequate to support its business at current operating levels, it continues to monitor new business opportunities and any associated new capital needs that could arise from the changing financial landscape.

The Holding Company

RGA is an insurance holding company whose primary uses of liquidity include, but are not limited to, the immediate capital needs of its operating companies, dividends paid to its shareholders, repurchase of common stock and interest payments on its indebtedness. The primary sources of RGA’s liquidity include proceeds from its capital-raising efforts, interest income on undeployed corporate investments, interest income received on surplus notes with RGA Reinsurance Company (“RGA Reinsurance”), RGA Life and Annuity Insurance Company (“RGA Life and Annuity”) and Rockwood Reinsurance Company (“Rockwood Re”) and dividends from operating subsidiaries. As the Company continues its growth efforts, RGA will continue to be dependent upon these sources of liquidity. The following tables provide comparative information for RGA (dollars in millions):

Three months ended June 30, 2024 2023 Six months ended June 30, 2024 2023
Interest and dividend income $23 $34 $56 $71
Interest expense 55 51 104 100
Capital contributions to subsidiaries 91 4 96 12
Issuance of unaffiliated debt 645 400 645 400
Dividends to shareholders 56 54 112 107
Purchases of treasury stock — 50 — 100
June 30, 2024 December 31, 2023
Cash and invested assets $949 $712

70

See Item 15, Schedule II – “Condensed Financial Information of the Registrant” in the 2023 Annual Report for additional financial information related to RGA.

The undistributed earnings of substantially all of the Company’s foreign subsidiaries have been reinvested indefinitely in those non-U.S. operations, as described in Note 14 – “Income Tax” in the Notes to Consolidated Financial Statements in the 2023 Annual Report. As U.S. Tax Reform generally eliminates U.S. federal income taxes on dividends from foreign subsidiaries, the Company does not expect to incur material income taxes if these funds are repatriated.

RGA endeavors to maintain a capital structure that provides financial and operational flexibility to its subsidiaries, credit ratings that support its competitive position in the financial services marketplace, and shareholder returns. As part of the Company’s capital deployment strategy, it has in recent years repurchased shares of RGA common stock and paid dividends to RGA shareholders, as authorized by the board of directors.

On January 23, 2024, RGA’s board of directors authorized a share repurchase program for up to $500 million of RGA’s outstanding common stock. The authorization was effective immediately and does not have an expiration date. During the six months ended June 30, 2024, RGA did not repurchase any shares under this program.

The pace of repurchase activity depends on various factors such as the level of available cash, an evaluation of the costs and benefits associated with alternative uses of excess capital, such as acquisitions and in force reinsurance transactions, and RGA’s stock price.

Details underlying dividend and share repurchase program activity were as follows (in millions, except share data):

Six months ended June 30, 2024 2023
Dividends to shareholders $112 $107
Purchase of treasury stock (1) — 100
Total amount paid to shareholders $112 $207
Number of treasury shares purchased (1) — 722,774
Average price per share $— $138.35

(1) Excludes shares utilized to execute and settle certain equity based compensation awards.

In August 2024, RGA’s board of directors declared a quarterly dividend of $0.89 per share. All future payments of dividends are at the discretion of RGA’s board of directors and will depend on the Company’s earnings, capital requirements, insurance regulatory conditions, operating conditions, and other such factors as the board of directors may deem relevant. The amount of dividends that RGA can pay will depend in part on the operations of its reinsurance subsidiaries. See Note 3 – “Equity” in the Notes to Condensed Consolidated Financial Statements for information on the Company’s share repurchase program.

Debt

Certain of the Company’s debt agreements contain financial covenant restrictions related to, among others, liens, the issuance and disposition of stock of restricted subsidiaries, minimum requirements of consolidated net worth, maximum ratios of debt to capitalization and change of control provisions. The Company renewed its syndicated credit facility in the first quarter of 2023. Under the terms of the facility the Company is required to maintain a minimum consolidated net worth, as defined in the debt agreements, of $6.3 billion. Subsequent to the adoption of ASU 2018-12, the minimum consolidated net worth, as defined in the debt agreements, was reduced to $5.8 billion effective with the June 30, 2023, covenant calculations. Also, consolidated indebtedness, calculated as of the last day of each fiscal quarter, cannot exceed 35% of the sum of the Company’s consolidated indebtedness plus adjusted RGA Inc.’s shareholders’ equity. A material ongoing covenant default could require immediate payment of the amount due, including principal, under the various agreements. Additionally, the Company’s debt agreements contain cross-acceleration covenants, which would make outstanding borrowings immediately payable in the event of a material uncured covenant default under any of the agreements, including, but not limited to, non-payment of indebtedness when due for an amount in excess of the amounts set forth in those agreements, bankruptcy proceedings, or any other event that results in the acceleration of the maturity of indebtedness.

As of June 30, 2024 and December 31, 2023, the Company had $5.1 billion and $4.5 billion, respectively, in outstanding borrowings under its debt agreements and was in compliance with all covenants under those agreements. As of June 30, 2024 and December 31, 2023, the average interest rate on long-term debt outstanding was 5.17% and 5.09%, respectively. The ability of the Company to make debt principal and interest payments depends on the earnings and surplus of subsidiaries, investment earnings on undeployed capital proceeds, available liquidity at the holding company, and the Company’s ability to raise additional funds.

The Company enters into derivative agreements with counterparties that reference either the Company’s debt rating or its financial strength rating. If either rating is downgraded in the future, it could trigger certain terms in the Company’s derivative agreements, which could negatively affect overall liquidity. For the majority of the Company’s derivative agreements, there is a termination event should the long-term senior debt ratings drop below either BBB+ (S&P) or Baa1 (Moody’s) or the financial strength ratings drop below either A- (S&P) or A3 (Moody’s).

The Company may borrow up to $850 million in cash and obtain letters of credit in multiple currencies on its revolving credit facility that matures in March 2028. As of June 30, 2024, the Company had no cash borrowings outstanding and no issued letters of credit under this facility.

On May 13, 2024, the Company issued 5.75% fixed rate Senior Notes due 2034 with a face amount of $650 million and will be used for general corporate purposes. Capitalized issuance costs were $6 million.

Based on the historic cash flows and the current financial results of the Company, management believes RGA’s cash flows will be sufficient to enable RGA to meet its obligations for at least the next 12 months.

Credit and Committed Facilities

The Company has obtained bank letters of credit in favor of various affiliated and unaffiliated insurance companies from which the Company assumes business. These letters of credit represent guarantees of performance under the reinsurance agreements and allow ceding companies to take statutory reserve credits. Certain of these letters of credit contain financial covenant restrictions similar to those described in the “Debt” discussion above. At June 30, 2024, there were approximately $52 million of outstanding bank letters of credit in favor of third parties. Additionally, in accordance with applicable regulations, the Company utilizes letters of credit to secure statutory reserve credits when it retrocedes business to its affiliated subsidiaries. The Company cedes business to its affiliates to help reduce the amount of regulatory capital required in certain jurisdictions, such as the U.S., Canada and UK. The Company believes the capital required to support the business in the affiliates reflects more realistic expectations than the original jurisdiction of the business, where capital requirements are often considered to be quite conservative. As of June 30, 2024, $1.6 billion in letters of credit from various banks were outstanding, but undrawn, backing reinsurance between the various subsidiaries of the Company.

On March 13, 2023, the Company entered into a syndicated revolving credit facility with a five year term and an overall capacity of $850 million. See Note 18 – “Financing Activities” in the Notes to Consolidated Financial Statements in the 2023 Annual Report for further information.

Cash Flows

The Company’s principal cash inflows from its reinsurance operations include premiums and deposit funds received from ceding companies. The primary liquidity concerns with respect to these cash flows are early recapture of the reinsurance contract by the ceding company and lapses of annuity products reinsured by the Company. The Company’s principal cash inflows from its invested assets result from investment income and the maturity and sales of invested assets. The primary liquidity concerns with respect to these cash inflows relates to the risk of default by debtors and interest rate volatility. The Company manages these risks very closely. See “Investments” below.

Additional sources of liquidity to meet unexpected cash outflows in excess of operating cash inflows and current cash and equivalents on hand also includes drawing funds under a revolving credit facility, under which the Company had availability of $850 million as of June 30, 2024. The Company also has $583 million of funds available through collateralized borrowings from the FHLB as of June 30, 2024. As of June 30, 2024, the Company could have borrowed these additional amounts without violating any of its existing debt covenants.

The Company’s principal cash outflows relate to the payment of claims liabilities, interest credited, operating expenses, income taxes, dividends to shareholders, purchases of treasury stock, and principal and interest under debt and other financing obligations. The Company seeks to limit its exposure to loss on any single insured and to recover a portion of benefits paid by ceding reinsurance to other insurance enterprises or reinsurers under excess coverage and coinsurance contracts. See Note 2 – “Significant Accounting Policies and Pronouncements” in the Notes to Consolidated Financial Statements in the 2023 Annual Report. The Company performs annual financial reviews of its retrocessionaires to evaluate financial stability and performance. The Company has never experienced a material default in connection with retrocession arrangements, nor has it experienced any difficulty in collecting claims recoverable from retrocessionaires; however, no assurance can be given as to the future performance of such retrocessionaires nor to the recoverability of future claims. The Company’s management believes its cash and cash equivalents as well as its current sources of liquidity are adequate to meet its cash requirements for the next 12 months.

Summary of Primary Sources and Uses of Liquidity and Capital

The Company’s primary sources and uses of liquidity and capital are summarized as follows (dollars in millions):

Sources: For the six months ended June 30, 2024 2023
Net cash provided by operating activities $6,703 $1,818
Proceeds from long-term debt issuance, net 640 890
Change in cash collateral for derivative positions and other arrangements 33 —
Change in deposit asset on reinsurance 151 24
Net deposits to investment-type policies and contracts 1,534 —
Total sources 9,061 2,732
Uses:
Net cash used in investing activities 7,176 2,488
Dividends to shareholders 112 107
Principal payments of long-term debt 2 2
Purchase of treasury stock 19 119
Change in cash collateral for derivative positions and other arrangements — 24
Net withdrawals from investment-type policies and contracts — 294
Effect of exchange rate changes on cash 126 27
Total uses 7,435 3,061
Net change in cash and cash equivalents $1,626 $(329)

Cash Flows from Operations – The principal cash inflows from the Company’s reinsurance activities come from premiums, investment and fee income, annuity considerations and deposit funds. The principal cash outflows relate to the liabilities associated with various life and health insurance, annuity and disability products, operating expenses, income tax payments and interest on outstanding debt obligations. The primary liquidity concern with respect to these cash flows is the risk of shortfalls in premiums and investment income, particularly in periods with abnormally high claims levels.

Cash Flows from Investments – The principal cash inflows from the Company’s investment activities come from repayments of principal on invested assets, proceeds from maturities of invested assets, sales of invested assets and settlements of freestanding derivatives. The principal cash outflows relate to purchases of investments, issuances of policy loans and settlements of freestanding derivatives. The Company typically has a net cash outflow from investing activities because cash inflows from insurance operations are reinvested in accordance with its asset/liability management discipline to fund insurance liabilities. The Company closely monitors and manages these risks through its credit risk management process. The primary liquidity concerns with respect to these cash flows are the risk of default by debtors and market disruption, which could make it difficult for the Company to sell investments.

Financing Cash Flows – The principal cash inflows from the Company’s financing activities come from issuances of RGA debt and equity securities, and deposit funds associated with universal life and other investment type policies and contracts. The principal cash outflows come from repayments of debt, payments of dividends to shareholders, purchases of treasury stock and withdrawals associated with universal life and other investment type policies and contracts. A primary liquidity concern with respect to these cash flows is the risk of early contractholder and policyholder withdrawal.

Contractual Obligations

There were no material changes in the Company’s contractual obligations from those reported in the 2023 Annual Report, except for the following:

  • The Company’s contractual obligations associated with future policy benefits increased $6.9 billion at June 30, 2024, due to new transactions executed during the year.
  • The Company’s contractual obligations associated with long term debt, including interest, increased $0.8 billion at June 30, 2024, primarily due to the issuance of the 2034 Senior Notes, see Note 17 – “Financing Activities” for further details.
  • The Company’s contractual obligations associated with other investment commitments increased $0.4 billion at June 30, 2024, primarily due to an increase in payables for securities sold or loaned under agreements to repurchase, see Note 10 – “Investments” for further details.

Asset / Liability Management

The Company actively manages its cash and invested assets using an approach that is intended to balance quality, diversification, asset/liability matching, liquidity and investment return. The goals of the investment process are to optimize after-tax, risk-adjusted investment income and after-tax, risk-adjusted total return while managing the assets and liabilities on a cash flow and duration basis.

The Company has established target asset portfolios for its operating segments, which represent the investment strategies intended to profitably fund its liabilities within acceptable risk parameters. These strategies include objectives and limits for effective duration, yield curve sensitivity and convexity, liquidity, asset sector concentration and credit quality.

The Company’s asset-intensive products are primarily supported by investments in fixed maturity securities reflected on the Company’s balance sheet and under funds withheld arrangements with the ceding company. Investment guidelines are established to structure the investment portfolio based upon the type, duration and behavior of products in the liability portfolio so as to achieve targeted levels of profitability. The Company manages the asset-intensive business to provide a targeted spread between the interest rate earned on investments and the interest rate credited to the underlying interest-sensitive contract liabilities. The Company periodically reviews models projecting different interest rate scenarios and their effect on profitability. Certain of these asset-intensive agreements, primarily in the U.S. and Latin America Financial Solutions operating segment, are generally funded by fixed maturity securities that are withheld by the ceding company.

The Company’s liquidity position (cash and cash equivalents and short term investments) was $4.9 billion and $3.2 billion at June 30, 2024 and December 31, 2023, respectively. Liquidity needs are determined from valuation analyses conducted by operational units and are driven by product portfolios. Periodic evaluations of demand liabilities and short-term liquid assets are designed to adjust specific portfolios, as well as their durations and maturities, in response to anticipated liquidity needs.

See “Securities Borrowing, Lending and Repurchase/Reverse Repurchase Agreements” in Note 10 – “Investments” in the Notes to Condensed Consolidated Financial Statements for information related to the Company’s securities borrowing, lending and repurchase/reverse repurchase programs. In addition to its security agreements with third parties, certain RGA subsidiaries have entered into intercompany securities lending agreements to more efficiently source securities for lending to third parties and to provide for more efficient regulatory capital management.

The Company is a member of the FHLB and holds $73 million of FHLB common stock, which is included in other invested assets on the Company’s condensed consolidated balance sheets. The Company has entered into funding agreements with the FHLB under guaranteed investment contracts whereby the Company has issued the funding agreements in exchange for cash and for which the FHLB has been granted a blanket lien on the Company’s commercial and residential mortgage-backed securities and commercial mortgage loans used to collateralize the Company’s obligations under the funding agreements. The Company maintains control over these pledged assets, and may use, commingle, encumber or dispose of any portion of the collateral as long as there is no event of default and the remaining qualified collateral is sufficient to satisfy the collateral maintenance level. The funding agreements and the related security agreements represented by this blanket lien provide that upon any event of default by the Company, the FHLB’s recovery is limited to the amount of the Company’s liability under the outstanding funding agreements. The amount of the Company’s liability for the funding agreements with the FHLB was $1.4 billion at June 30, 2024 and $1.1 billion at December 31, 2023, which is included in interest-sensitive contract liabilities on the Company’s condensed consolidated balance sheets. The advances on these agreements are collateralized primarily by commercial and residential mortgage-backed securities, commercial mortgage loans, and U.S. Treasury and government agency securities. The amount of collateral exceeds the liability and is dependent on the type of assets collateralizing the guaranteed investment contracts.

Investments

Management of Investments

The Company’s investment and derivative strategies involve matching the characteristics of its reinsurance products and other obligations. The Company seeks to closely approximate the interest rate sensitivity of the assets with estimated interest rate sensitivity of the reinsurance liabilities. The Company achieves its income objectives through strategic and tactical asset allocations, applying security and derivative strategies within asset/liability and disciplined risk management frameworks. Derivative strategies are employed within the Company’s risk management framework to help manage duration, currency, and other risks in assets and/or liabilities and to replicate the credit characteristics of certain assets.

The Company’s portfolio management groups work with the Enterprise Risk Management function to develop the investment policies for the assets of the Company’s domestic and international investment portfolios. All investments held by the Company, directly or in a funds withheld at interest reinsurance arrangement, are monitored for conformance with the Company’s stated investment policy limits as well as any limits prescribed by the applicable jurisdiction’s insurance laws and regulations. See Note 10 – “Investments” in the Notes to Condensed Consolidated Financial Statements for additional information regarding the Company’s investments.

Portfolio Composition

The Company had total cash and invested assets of $94.2 billion and $81.9 billion as of June 30, 2024 and December 31, 2023, respectively, as illustrated below (dollars in millions):

June 30, 2024 % of Total December 31, 2023 % of Total
Fixed maturity securities available-for-sale $70,491 74.7% $60,467 73.9%
Equity securities 144 0.2 139 0.2
Mortgage loans 7,984 8.5 7,377 9.0
Policy loans 1,171 1.2 1,206 1.5
Funds withheld at interest 5,556 5.9 5,683 6.9
Limited partnerships and real estate joint ventures 2,791 3.0 2,635 3.2
Short-term investments 335 0.4 222 0.3
Other invested assets 1,148 1.2 1,171 1.4
Cash and cash equivalents 4,596 4.9 2,970 3.6
Total cash and invested assets $94,216 100.0% $81,870 100.0%

Investment Yield

The following table presents consolidated average invested assets at amortized cost, net investment income, investment yield, variable investment income (“VII”) and investment yield excluding VII, which can vary significantly from period to period (dollars in millions). The table excludes spread related business. Spread related business is primarily associated with contracts on which the Company earns an interest rate spread between assets and liabilities. To varying degrees, fluctuations in the yield on other spread related business is generally subject to corresponding adjustments to the interest credited on the liabilities.

Three months ended June 30, 2024 2023 Increase / (Decrease) Six months ended June 30, 2024 2023 Increase / (Decrease)
Average invested assets at amortized cost $38,172 $36,124 $2,048 $38,106 $35,792 $2,314
Net investment income $436 $393 $43 $880 $808 $72
Annualized investment yield (ratio of net investment income to average invested assets at amortized cost) 4.65% 4.42% 23 bps 4.67% 4.56% 11 bps
VII (included in net investment income) $12 $17 $(5) $28 $56 $(28)
Annualized investment yield excluding VII (ratio of net investment income, excluding VII, to average invested assets, excluding assets with only VII, at amortized cost) 4.76% 4.43% 33 bps 4.76% 4.44% 32 bps

Investment yield increased for the three months ended June 30, 2024 and the six months ended June 30, 2024, in comparison to the same periods in the prior year, primarily due to higher new money rates, partially offset by decreased variable income from real estate joint ventures.

Fixed Maturity Securities Available-for-Sale

See “Fixed Maturity Securities Available-for-Sale” in Note 10 – “Investments” in the Notes to Condensed Consolidated Financial Statements for tables that provide the amortized cost, allowance for credit losses, unrealized gains and losses and estimated fair value of these securities by type as of June 30, 2024 and December 31, 2023.

Important factors in the selection of investments include diversification, quality, yield, call protection and total rate of return potential. The relative importance of these factors is determined by market conditions and the underlying reinsurance liability and existing portfolio characteristics. As of June 30, 2024 and December 31, 2023, approximately 94.4% and 94.3%, respectively, of the Company’s consolidated investment portfolio of fixed maturity securities were investment grade.

The Company owns floating rate securities that represent approximately 8.2% and 7.7% of the total fixed maturity securities as of June 30, 2024 and December 31, 2023, respectively. These investments have a higher degree of income variability than the other fixed income holdings in the portfolio due to fluctuations in interest payments. The Company holds floating rate investments to enhance asset management strategies and match certain interest-sensitive contract liabilities.

The largest asset class in which fixed maturity securities were invested was corporate securities, which represented approximately 65.4% and 64.1% of total fixed maturity securities as of June 30, 2024 and December 31, 2023, respectively. See “Corporate Fixed Maturity Securities” in Note 10 – “Investments” in the Notes to Condensed Consolidated Financial Statements for tables showing the major sector types, which comprise the corporate fixed maturity holdings as of June 30, 2024 and December 31, 2023.

As of June 30, 2024 and December 31, 2023, the Company’s investments in Canadian government securities represented 6.8% and 6.5%, respectively, of the fair value of total fixed maturity securities. These assets are primarily high quality, long duration provincial strip bonds, the valuation of which is closely linked to the interest rate curve. These assets are longer in duration and held primarily for asset/liability management to meet Canadian regulatory requirements.

As of June 30, 2024 and December 31, 2023, the Company’s investments in Japanese government securities represented 6.3% and 5.2%, respectively, of the fair value of total fixed maturity securities. These assets are primarily long duration government bonds matching the liability profile of the Company’s Japanese business.

The Company references rating agency designations in some of its investments disclosures. These designations are based on the ratings from nationally recognized statistical rating organizations, primarily Moody’s, S&P and Fitch. Structured securities held by the Company’s insurance subsidiaries that maintain the NAIC statutory basis of accounting utilize the NAIC rating methodology. The NAIC assigns designations to publicly traded as well as privately placed securities. The designations assigned by the NAIC range from class 1 to class 6, with designations in classes 1 and 2 generally considered investment grade (BBB or higher rating agency designation). NAIC designations in classes 3 through 6 are generally considered below investment grade (BB or lower rating agency designation). If no rating is available from a rating agency or the NAIC, then an internally developed rating is used.

The quality of the Company’s available-for-sale fixed maturity securities portfolio, as measured at fair value and by the percentage of fixed maturity securities invested in various ratings categories, relative to the entire available-for-sale fixed maturity securities portfolio, as of June 30, 2024 and December 31, 2023 was as follows (dollars in millions):

NAIC Designation Rating Agency Designation June 30, 2024 Amortized Cost Estimated Fair Value % of Total December 31, 2023 Amortized Cost Estimated Fair Value % of Total
1 AAA/AA/A $49,634 $45,782 64.9% $41,469 $38,739 64.1%
2 BBB 22,431 20,787 29.5 19,793 18,261 30.2
3 BB 3,331 3,270 4.6 3,068 2,956 4.9
4 B 562 504 0.8 479 396 0.7
5 CCC and lower 158 124 0.2 116 92 0.1
6 In or near default 45 24 — 52 23 —
Total $76,161 $70,491 100.0% $64,977 $60,467 100.0%

The Company’s fixed maturity portfolio includes structured securities. The following table shows the types of structured securities the Company held as of June 30, 2024 and December 31, 2023 (dollars in millions):

ABS: June 30, 2024 Amortized Cost Estimated Fair Value % of Total December 31, 2023 Amortized Cost Estimated Fair Value % of Total
Collateralized loan obligations (“CLOs”) $2,675 $2,676 31.6% $2,086 $2,048 28.1%
ABS, excluding CLOs 2,627 2,467 29.1 2,575 2,381 32.7
Total ABS 5,302 5,143 60.7 4,661 4,429 60.8
CMBS 2,242 2,120 25.0 1,969 1,773 24.3
RMBS:
Agency 414 364 4.3 444 398 5.5
Non-agency 893 848 10.0 729 681 9.4
Total RMBS 1,307 1,212 14.3 1,173 1,079 14.9
Total $8,851 $8,475 100.0% $7,803 $7,281 100.0%

The Company’s ABS portfolio primarily consists of CLOs, aircraft and NAV loans. The principal risks in holding ABS are structural, credit, capital market and interest rate risks. Structural risks include the securities’ cash flow priority in the capital structure and the inherent prepayment sensitivity of the underlying collateral. Credit risks include the adequacy and ability to realize proceeds from the collateral. Credit risks are mitigated by credit enhancements that include excess spread, over-collateralization and subordination. Capital market risks include general level of interest rates and the liquidity for these securities in the marketplace.

The Company’s CMBS portfolio primarily consists of large pool securitizations that are diverse by property type, borrower and geographic dispersion. The principal risks in holding CMBS are structural and credit risks. Structural risks include the securities’ cash flow priority in the capital structure and the inherent prepayment sensitivity of the underlying collateral. Credit risks include the adequacy and ability to realize proceeds from the collateral. The Company focuses on investment grade rated tranches that provide additional credit support beyond the equity protection in the underlying loans. These assets are viewed as an attractive alternative to other fixed income asset classes.

The Company’s RMBS portfolio includes agency-issued pass-through securities and collateralized mortgage obligations. Agency-issued pass-through securities are guaranteed or otherwise supported by the Federal Home Loan Mortgage Corporation, Federal National Mortgage Association, or the Government National Mortgage Association. The principal risks inherent in holding RMBS are prepayment and extension risks, which will affect the timing of when cash will be received and are dependent on the level of mortgage interest rates. Prepayment risk is the unexpected increase in principal payments from the expected, primarily as a result of owner refinancing. Extension risk relates to the unexpected slowdown in principal payments from the expected. In addition, non-agency RMBS face credit risk should the borrower be unable to pay the contractual interest or principal on their obligation. The Company monitors its mortgage-backed securities to mitigate exposure to the cash flow uncertainties associated with these risks.

As of June 30, 2024 and December 31, 2023, the Company had $6.5 billion and $5.6 billion, respectively, of gross unrealized losses related to its fixed maturity securities. The Company monitors its fixed maturity securities to determine impairments in value and evaluates factors such as financial condition of the issuer, payment performance, compliance with covenants, general market and industry sector conditions, current intent and ability to hold securities, and various other subjective factors. Based on management’s judgment, an allowance for credit losses in the amount that fair value is less than the amortized cost is recorded for securities determined to have expected credit losses.

Mortgage Loans

The Company’s mortgage loan portfolio consists of U.S., Canada and UK based investments primarily in retail locations, light industrial properties, and commercial offices. The mortgage loan portfolio is diversified by geographic region and property type as discussed further under “Mortgage Loans” in Note 10 – “Investments” in the Notes to Condensed Consolidated Financial Statements. Most of the mortgage loans in the Company’s portfolio range in size up to $45 million, with the average mortgage loan investment as of June 30, 2024, totaling approximately $10 million.

As of June 30, 2024 and December 31, 2023, the Company’s recorded investment in mortgage loans, gross of unamortized deferred loan origination fees and expenses and allowance for credit losses, were distributed geographically as follows (dollars in millions):

U.S. Region: June 30, 2024 Recorded Investment % of Total December 31, 2023 Recorded Investment % of Total
West $2,971 36.8% $2,806 37.6%
South 2,534 31.4 2,472 33.1
Midwest 1,203 14.9 1,163 15.6
Northeast 553 6.8 541 7.3
Subtotal – U.S. 7,261 89.9 6,982 93.6
Canada 611 7.6 301 4.0
United Kingdom 204 2.5 176 2.4
Total $8,076 100.0% $7,459 100.0%

See “Allowance for Credit Losses and Impairments” in Note 2 – “Significant Accounting Policies and Pronouncements” of the Company’s 2023 Annual Report and “Mortgage Loans” in Note 10 – “Investments” in the Notes to Condensed Consolidated Financial Statements for information regarding the Company’s policy for allowance for credit losses on mortgage loans.

Allowance for Credit Losses and Impairments

The table below summarizes investment related gains (losses), net related to allowances for credit losses and impairments for the three and six months ended June 30, 2024 and 2023 (dollars in millions):

2024 Three months ended June 30, 2023 2024 Six months ended June 30, 2023
Change in allowance for credit losses on fixed maturity securities $(16) $4 $(36) $(38)
Impairments on fixed maturity securities (1) — (1) (1)
Change in mortgage loan allowance for credit losses 2 (9) (8) (6)
Limited partnerships and real estate joint ventures impairment losses — — (8) —
Other impairment losses (3) — (4) —
Investment related gains (losses) related to credit losses and impairments $(18) $(5) $(57) $(45)

77

The Company’s determination of whether a decline in value necessitates the recording of an allowance for credit losses includes an analysis of whether the issuer is current on its contractual payments, evaluating whether it is probable that the Company will be able to collect all amounts due according to the contractual terms of the security and analyzing the overall ability of the Company to recover the amortized cost of the investment. See “Allowance for Credit Losses and Impairments” in Note 2 – “Significant Accounting Policies and Pronouncements” of the Company’s 2023 Annual Report for additional information.

See “Unrealized Losses for Fixed Maturity Securities Available-for-Sale” in Note 10 – “Investments” in the Notes to Condensed Consolidated Financial Statements for tables that present the estimated fair value and gross unrealized losses for securities that have estimated fair values below amortized cost by class and grade, as well as the length of time the related estimated fair value has remained below amortized cost as of June 30, 2024 and December 31, 2023.

As of June 30, 2024 and December 31, 2023, the Company classified approximately 10.0% and 10.6%, respectively, of its fixed maturity securities in the Level 3 category. Refer to Note 12 – “Fair Value of Assets and Liabilities” in the Notes to Condensed Consolidated Financial Statements for additional information. These securities primarily consist of private placement corporate and asset-backed securities.

See “Securities Lending and Repurchase/Reverse Repurchase Agreements” in Note 10 – “Investments” in the Notes to Condensed Consolidated Financial Statements for information related to the Company’s securities lending and repurchase/reverse repurchase agreements.

Funds Withheld at Interest

For reinsurance agreements written on a modified coinsurance basis and certain agreements written on a coinsurance basis, assets equal to the net statutory reserves are withheld and legally owned and managed by the ceding company and are reflected as funds withheld at interest on the Company’s condensed consolidated balance sheets. In the event of a ceding company’s insolvency, the Company would need to assert a claim on the assets supporting its reserve liabilities. However, the risk of loss to the Company is mitigated by its ability to offset amounts it owes the ceding company for claims or allowances against amounts owed by the ceding company. Interest accrues to the total funds withheld at rates defined by the treaty terms. The Company is subject to the investment performance on the withheld assets, although it does not directly control them. These assets are primarily fixed maturity investment securities and pose risks similar to the fixed maturity securities the Company owns. To mitigate this risk, the Company helps set the investment guidelines followed by the ceding company and monitors compliance. Ceding companies with funds withheld at interest had an average financial strength rating of “A” as of June 30, 2024 and December 31, 2023. Certain ceding companies maintain segregated portfolios for the benefit of the Company.

Other Invested Assets

Other invested assets primarily include lifetime mortgages, derivative contracts, FHLB common stock and real estate held for investment. See “Other Invested Assets” in Note 10 – “Investments” in the Notes to Condensed Consolidated Financial Statements for a table that presents the carrying value of the Company’s other invested assets by type as of June 30, 2024 and December 31, 2023.

The Company utilizes derivative financial instruments to protect the Company against possible changes in the fair value of its investment portfolio as a result of interest rate changes, to hedge against risk of changes in the purchase price of securities, to hedge liabilities associated with the reinsurance of variable annuities with guaranteed living benefits and to manage the portfolio’s effective yield, maturity and duration. In addition, the Company utilizes derivative financial instruments to reduce the risk associated with fluctuations in foreign currency exchange rates. The Company uses exchange-traded, centrally cleared, and customized over-the-counter derivative financial instruments.

See Note 11 – “Derivative Instruments” in the Notes to Condensed Consolidated Financial Statements for a table that presents the notional amounts and fair value of investment related derivative instruments held as of June 30, 2024 and December 31, 2023.

The Company may be exposed to credit-related losses in the event of non-performance by counterparties to derivative financial instruments. Generally, the credit exposure of the Company’s derivative contracts is limited to the fair value and accrued interest of non-collateralized derivative contracts in an asset position at the reporting date. As of June 30, 2024, the Company had credit exposure of $14 million.

The Company manages its credit risk related to over-the-counter derivatives by entering into transactions with creditworthy counterparties, maintaining collateral arrangements and through the use of master agreements that provide for a single net payment to be made by one counterparty to another at each due date and upon termination. As exchange-traded futures are affected through regulated exchanges, and positions are marked to market on a daily basis, the Company has minimal exposure to credit-related losses in the event of nonperformance by counterparties. See Note 12 – “Derivative Instruments” in the Notes to Condensed Consolidated Financial Statements for more information regarding the Company’s derivative instruments.

The Company holds $951 million and $944 million of beneficial interest in lifetime mortgages in the UK, net of allowance for credit losses, as of June 30, 2024 and December 31, 2023, respectively. Investment income includes $10 million and $8 million in interest income earned on lifetime mortgages for the three months ended June 30, 2024 and 2023, respectively, and $21 million and $18 million in interest income earned on lifetime mortgages for the six months ended June 30, 2024 and 2023, respectively. Lifetime mortgages represent loans provided to individuals 55 years of age and older secured by the borrower’s residence. Lifetime mortgages are comparable to a home equity loan by allowing the borrower to utilize the equity in their home as collateral. The amount of the loan is dependent on the appraised value of the home at the time of origination, the borrower's age and interest rate. Unlike a home equity loan, no payment of principal or interest is required until the death of the borrower or sale of the home. Lifetime mortgages may also be either fully funded at origination, or the borrower can request periodic funding similar to a line of credit. Lifetime mortgages are subject to risks, including market, credit, interest rate, liquidity, operational, reputational and legal risks.

New Accounting Standards

Changes to the general accounting principles are established by the Financial Accounting Standards Board (“FASB”) in the form of accounting standards updates to the FASB Accounting Standards CodificationTM.

See Note 18 – “New Accounting Standards” in the Notes to Condensed Consolidated Financial Statements for information on new accounting pronouncements and their impact, if any, on the Company’s results of operations and financial position.

Market risk

As filed, 855 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Market risk is the risk of fluctuations in the value of financial instruments as a result of absolute or relative changes in interest rates, foreign currency exchange rates, equity prices or commodity prices. To varying degrees, the Company products and services, and the investment activities supporting them, generate exposure to market risk. The market risk incurred, and the Company’s strategies for managing this risk, vary by product. As of June 30, 2024, there have been no material changes in the Company’s economic exposure to market risk or the Company’s Enterprise Risk Management function from December 31, 2023, a description of which may be found in its Annual Report on Form 10-K, for the year ended December 31, 2023, Item 7A, “Quantitative and Qualitative Disclosures about Market Risk,” filed with the Securities and Exchange Commission.

Controls and procedures

As filed, 719 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The Chief Executive Officer and the Chief Financial Officer have evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures as defined in Exchange Act Rule 13a-15(e) as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that these disclosure controls and procedures were effective.

There was no change in the Company’s internal control over financial reporting as defined in Exchange Act Rule 13a-15(f) during the quarter ended June 30, 2024, that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2024-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2024-04-01 to 2024-06-30$4.88bnus-gaap:Revenues
Revenue6 months2024-01-01 to 2024-06-30$11.21bnus-gaap:Revenues
Interest expense3 months2024-04-01 to 2024-06-30$72.0mus-gaap:InterestExpense
Interest expense6 months2024-01-01 to 2024-06-30$140.0mus-gaap:InterestExpense
Income tax3 months2024-04-01 to 2024-06-30$65.0mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2024-01-01 to 2024-06-30$125.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2024-04-01 to 2024-06-30$203.0mus-gaap:NetIncomeLoss
Net income6 months2024-01-01 to 2024-06-30$413.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2024-04-01 to 2024-06-30$3.03us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2024-01-01 to 2024-06-30$6.19us-gaap:EarningsPerShareDiluted
Basic EPS3 months2024-04-01 to 2024-06-30$3.07us-gaap:EarningsPerShareBasic
Basic EPS6 months2024-01-01 to 2024-06-30$6.28us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2024-04-01 to 2024-06-3067,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2024-01-01 to 2024-06-3067,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2024-01-01 to 2024-06-30−$6.70bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Dividends paid6 months2024-01-01 to 2024-06-30$112.0mus-gaap:PaymentsOfDividends
Cash and equivalentsAt period end2024-06-30$4.60bnus-gaap:CashAndCashEquivalentsAtCarryingValue
Total assetsAt period end2024-06-30$109.89bnus-gaap:Assets
Total liabilitiesAt period end2024-06-30$100.06bnus-gaap:Liabilities
Long-term debtAt period end2024-06-30$5.07bnus-gaap:LongTermDebt
Shareholders' equityAt period end2024-06-30$9.73bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000898174-24-000130. Last ingested by Listed: Nov 5, 2026, 18:26 ET. Listed shows no prices and gives no investment advice.